Electroacupuncture Improves Gastrointestinal Motility in Rats with Functional Dyspepsia via the GDNF/GFRα1/PI3K/Akt Signaling Pathway

Abstract

Objective

Abnormal gastrointestinal motility plays a crucial role in the pathogenesis of functional dyspepsia (FD). Although electroacupuncture (EA) has demonstrated efficacy in FD treatment, its precise mechanism remains unclear. This study aimed to elucidate the specific mechanism through which EA improves gastrointestinal motility in FD.

Methods

Physiological indices, including body weight, food intake, gastrointestinal motility, and gastrointestinal morphology, were utilized to assess the FD model in rats. EA interventions were applied at meridian points, as well as non-meridian points and non-acupoints, in FD model rats. The effects of EA at zusanli (ST36) and taichong (LR3) on gastrointestinal motility in FD model rats were elucidated using gastrointestinal motility test indices. Techniques such as Western blotting, quantitative real-time PCR, and immunofluorescence were employed to determine the specific mechanisms by which EA improved gastrointestinal motility in FD model rats.

Results

Multifactorial stress intervention could be used to effectively establish an FD rat model. EA at ST36 and LR3 significantly improved gastrointestinal motility. Furthermore, EA at ST36 and LR3 upregulated the protein expression of glial cell line-derived neurotrophic factor (GDNF), GDNF family receptor alpha 1 (GFRα1), phosphatidylinositol 3-kinase (PI3K), and protein kinase B (Akt), along with their mRNA expression levels and the number of enteric glial cells (EGCs).

Conclusions

EA was capable of increasing the number of EGCs by activating the GDNF/GFRα1/PI3K/Akt signaling pathway, thereby improving gastrointestinal motility in FD.

Keywords

Functional dyspepsia / Electroacupuncture / Enteric nervous system / Enteric glial cell / Gastrointestinal motility

References

[1] FordAC, MahadevaS, CarboneMF, et al.. Functional dyspepsia. Lancet., 2020, 396(10263): 1689-1702.

[2] PotterMDE, TalleyNJ. Editorial: new insights into the global prevalence of uninvestigated and functional dyspepsia. Aliment Pharmacol Ther., 2020, 52(8): 1407-1408.

[3] DragoL, MeroniG, PistoneD, et al.. Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies. J Int Med Res., 2021, 49(1): 1-13.

[4] LongYQ, XuWL, LiLX, et al.. Characteristics and risk factors of functional dyspepsia fulfilling the Rome IV criteria overlapping with gastroesophageal reflux disease, irritable bowel syndrome, and functional constipation in South China. J Neurogastroenterol Motil., 2024, 30(2): 184-193.

[5] OlsonCG, TraversP, LacyBE. Current opinion: functional dyspepsia. Curr Opin Gastroenterol., 2024, 40(6): 470-476.

[6] WautersL, TalleyNJ, WalkerMM, et al.. Novel concepts in the pathophysiology and treatment of functional dyspepsia. Gut., 2020, 69(3): 591-600.

[7] OshimaT. Functional dyspepsia: current understanding and future perspective. Digestion., 2024, 105(1): 26-33.

[8] AsanoH, TomitaT, NakamuraK, et al.. Prevalence of gastric motility disorders in patients with functional dyspepsia. J Neurogastroenterol Motil., 2017, 23(3): 392-399.

[9] SayukGS, GyawaliCP. Functional dyspepsia: diagnostic and therapeutic approaches. Drugs., 2020, 80(13): 1319-1336.

[10] SpencerNJ, HuH. Enteric nervous system: sensory transduction, neural circuits and gastrointestinal motility. Nat Rev Gastroenterol Hepatol., 2020, 17(6): 338-351.

[11] WrightCM, SchneiderS, Smith-EdwardsKM, et al.. scRNA-Seq reveals new enteric nervous system roles for GDNF, NRTN, and TBX3. Cell Mol Gastroenterol Hepatol., 2021, 11(5): 1548-1592.e1.

[12] SeguellaL, GulbransenBD. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol., 2021, 18(8): 571-587.

[13] AhmadzaiMM, SeguellaL, GulbransenBD. Circuit-specific enteric glia regulate intestinal motor neurocircuits. Proc Natl Acad Sci USA, 2021, 11840. e2025938118

[14] Sun LQ, Zhang W, Wei T, et al. Effects of electroacupuncture at Shu acupoints and Mu acupoints of large intestine merdianon GDNF-PI3K-Akt signal transduction pathway in functional constipation model mice. J TCM (Chinese). 2018;59(12):1045–1048.

[15] ZhangT, LiuW, LuH, et al.. Lactic acid bacteria in relieving constipation: mechanism, clinical application, challenge, and opportunity. Crit Rev Food Sci Nutr., 2025, 65(3): 551-574.

[16] ShangR, ZhouL, ZhangH. Study on Mechanism of electroacupuncture improving gastric motility in FD model rats based on PI3K/Akt signaling pathway. Acta Med Univ Sci Technol Huazhong (Chinese), 2025, 54(1): 67-72

[17] TalleyNJ. Functional dyspepsia: new insights into pathogenesis and therapy. Korean J Intern Med., 2016, 31(3): 444-456.

[18] YangJW, WangLQ, ZouX, et al.. Effect of acupuncture for postprandial distress syndrome: a randomized clinical trial. Ann Intern Med., 2020, 172(12): 777-785.

[19] YangNN, TanCX, LinLL, et al.. Potential mechanisms of acupuncture for functional dyspepsia based on pathophysiology. Front Neurosci., 2021, 15. 781215

[20] ZhuY, XuF, LuD, et al.. Transcutaneous auricular vagal nerve stimulation improves functional dyspepsia by enhancing vagal efferent activity. Am J Gastrointest Liver Physiol., 2021, 320(5): G700-G711.

[21] HuJS. The World Health Organization has endorsed acupuncture for the treatment of 43 diseases. J TCM (Chinese), 1989, 0857

[22] DuYH, LiJ, SunDW, et al.. Study on modern disease menu of acupuncture and moxibustion therapy in China. Chin Acupunct Moxibustion (Chinese), 2007, 27(5): 373-378

[23] China Association of Acupuncture-Moxibustion. Names and locations of commonly used acupuncture points in laboratory animals-Part 2: Rats. Acupunct Res (Chinese), 2021, 46(4): 351-352

[24] LiL, JiaQ, WangX, et al.. Chaihu Shugan San promotes gastric motility in rats with functional dyspepsia by regulating Drp-1-mediated ICC mitophagy. Pharm Biol., 2023, 61(1): 249-258.

[25] ZhangJ, WangX, WangF, et al.. Xiangsha Liujunzi decoction improves gastrointestinal motility in functional dyspepsia with spleen deficiency syndrome by restoring mitochondrial quality control homeostasis. Phytomedicine., 2022, 105. 154374

[26] XiaoHL, XiaoYJ, WangQ, et al.. Moxibustion regulates gastrointestinal motility via HCN1 in functional dyspepsia rats. Med Sci Monit., 2021, 27. e932885

[27] TuY, LuoX, LiuD, et al.. Extracts of Poria cocos improve functional dyspepsia via regulating brain-gut peptides, immunity and repairing of gastrointestinal mucosa. Phytomedicine., 2022, 95. 153875

[28] TianS, CaoL, MiaoM, et al.. A new method for the evaluation of animal models used in traditional Chinese Medicine based on the clinical characteristics of Chinese and Western medicine. Pharmacol Clin Chin Mater Med (Chinese), 2017, 33(6): 165-169

[29] Spleen and Stomach Diseases Branch of China Association of Chinese Medicine. Guidelines on Chinese Medicine Diagnosis and Treatment of Functional Dyspepsia in Common Disease of Digestive System. Chin J Trad Chin Med Pharm (Chinese), 2019, 8(34): 3619-3625

[30] OhkuraT, BurnsAJ, HottaR. Updates and challenges in ENS cell therapy for the treatment of neurointestinal diseases. Biomolecules., 2024, 142229.

[31] GrundmannD, LorisE, Maas-OmlorS, et al.. Enteric Glia: S100, GFAP, and Beyond. Anat Rec (Hoboken)., 2019, 302(8): 1333-1344.

[32] BonafinaA, FontanetPA, ParatchaG, et al.. GDNF/GFRα1 Complex abrogates self-renewing activity of cortical neural precursors inducing their differentiation. Stem Cell Rep., 2018, 10(3): 1000-1015.

[33] ChenG, DuY, LiX, et al.. Lower GDNF serum level is a possible risk factor for constipation in patients with Parkinson disease: a case-control study. Front Neurol., 2021, 12. 777591

[34] ChenY, LiuG, HeF, et al.. MicroRNA 375 modulates hyperglycemia-induced enteric glial cell apoptosis and Diabetes-induced gastrointestinal dysfunction by targeting Pdk1 and repressing PI3K/Akt pathway. Sci Rep., 2018, 8112681.

[35] LiB, LuoXF, LiuSW, et al.. Abdominal massage reduces visceral hypersensitivity via regulating GDNF and PI3K/AKT signal pathway in a rat model of irritable bowel syndrome. Evid Based Complement Alternat Med., 2020, 20203912931.

[36] GuoJR, WangH, JinXJ, et al.. Effect and mechanism of inhibition of PI3K/Akt/mTOR signal pathway on chronic neuropathic pain and spinal microglia in a rat model of chronic constriction injury. Oncotarget., 2017, 8(32): 52923-52934.

[37] TravagliRA, AnselmiL. Vagal neurocircuitry and its influence on gastric motility. Nat Rev Gastroenterol Hepatol., 2016, 13(7): 389-401.

Funding

The Research Fund of Jianghan University(2024JCYJ13)

Science and Technology Research Program of Department of Education of Hubei Province(Q20234413)

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to Huazhong University of Science and Technology